
Pharmaceuticals & Healthcare · NSE / BSE
Sai Life Sciences Limited, incorporated in January 1999, specializes in researching, developing, and manufacturing small-molecule new chemical entities, serving over 280 innovator pharmaceutical companies in FY 2024, including more than 230 clients as of September 2024. Collaborating with 18 of the top 25 global pharmaceutical firms, the company provides services across the US, UK, Europe, and Japan, offering CMC/CDMO capabilities, integrated discovery through CRO services, and support in biology, chemistry, and pharmacokinetics. Supported by a workforce of 3,135 employees, including 2,353 scientific staff with 302 Ph.D.s and 1,475 master’s degrees, Sai Life Sciences drives innovation with a globally positioned business development team of 16 professionals.
Price Band
₹522 – ₹549
Issue Size
₹3043 Cr
Lot Size
27 shares
GMP
+12.9%
Est. Listing
₹620
at current GMP
Subscribed
10.27x
overall
Open
11 Dec 2024
Close
13 Dec 2024
Allotment
16 Dec 2024
Refund
17 Dec 2024
Demat Credit
18 Dec 2024
Listing
18 Dec 2024